MK Proteins Q2 Results FY27: Revenue Jumps 37.1% to Rs 44.46 Cr, PAT Rs 0.87 Cr

MK Proteins Ltd (MKPL) Q2 Results FY27 announced on 13 November 2026, covering the company's financial performance for the July to September quarter. Revenue stood at Rs 44.46 Cr, Operating Profit at Rs 1.47 Cr and net profit (PAT) at Rs 0.87 Cr, all on a standalone basis. The results date and the standalone results basis frame the numbers below, and MK Proteins Q2 Results FY27 are the headline reference on NSE and BSE.

This MK Proteins Q2 Results review offers a structured results analysis of the quarter. It walks through the financial highlights, the business factors disclosed with the numbers, the FY27 outlook and the risks to watch, and it begins with the Financial Highlights table that places the latest figures next to the same quarter of last year.

Click Here – Get Free Investment Predictions

MK Proteins Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 44.46 Cr	Rs 32.43 Cr	+37.1% YoY
Operating Profit	Rs 1.47 Cr	Rs 1.05 Cr	+40% YoY
Net Profit (PAT)	Rs 0.87 Cr	Rs 0.75 Cr	+16% YoY

Source: company filing for MK Proteins Q2 Results FY27, 13 November 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from MK Proteins Q2 Results: What Stands Out

• Revenue of Rs 44.46 Cr was 37.1% above the Rs 32.43 Cr recorded in the same quarter of last year.
• Operating Profit of Rs 1.47 Cr compares with Rs 1.05 Cr a year earlier, a YoY growth of 40% in the quarter.
• Net profit of Rs 0.87 Cr rose 16% from Rs 0.75 Cr, which is the figure at the centre of MK Proteins Q2 Results FY27.
• Standalone basis applies to every number here, so the figures describe the company on its own and not a wider group.
• Balance sheet ratios such as debt at 0.47 times total assets in FY26 sit in the risk section, after the performance analysis below.

MK Proteins Q2 Results FY27: Performance Analysis

MK Proteins reported standalone revenue of Rs 44.46 Cr, Operating Profit of Rs 1.47 Cr and net profit of Rs 0.87 Cr for July to September 2026. Revenue rose 37.1%, Operating Profit rose 40% and net profit rose 16% against the same quarter of last year, so all three lines moved higher YoY.

In MK Proteins Q2 Results FY27, the quarterly results show revenue adding Rs 12.03 Cr to the Rs 32.43 Cr base, while Operating Profit added Rs 0.42 Cr and net profit added Rs 0.12 Cr. This results analysis rests on plain differences between the two standalone columns filed on the exchanges.

Readers of MK Proteins Q2 Results will also see that the three growth rates differ, with revenue and Operating Profit rising faster than net profit. That YoY growth pattern is a matter of arithmetic across the columns, and the business factors behind it come next.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The business factors begin with revenue, which grew 37.1% year on year to Rs 44.46 Cr in the latest quarter. This top-line expansion is the first disclosed factor and it sets the scale for every other standalone figure in the filing.

Operating Profit Gain – Operating Profit reached Rs 1.47 Cr against Rs 1.05 Cr a year earlier, a rise of 40%. The gain sits alongside the higher revenue and is the second disclosed factor, as reported when MK Proteins Q2 Results FY27 were declared.

Net Profit Rise – Net profit rose 16.0% year on year to Rs 0.87 Cr. This third factor completes the picture from revenue down to the bottom line, and it shows how the quarterly results look at the final profit stage.

FY27 Outlook After MK Proteins Q2 Results

The results analysis for FY27 depends on the quarters still to be reported. MK Proteins Q2 Results FY27 give one standalone data point of Rs 44.46 Cr revenue and Rs 0.87 Cr net profit, and the full-year picture will form as the company declares each later quarter.

This section therefore avoids any forecast and keeps to the declared figures. Investors can compare net profit and revenue again when the next filing arrives, and the Univest Screener helps follow those updates for MKPL beside other listed names. That brings the discussion to the risks worth watching.

Key Risks to Watch After MK Proteins Q2 Results FY27

Low Return on Equity

Return on equity was low at 9.37% in FY26. Even with YoY growth in the latest quarter, this ratio shows how modest the returns on shareholder capital were across the last full financial year.

High Debt Level

Debt is high at 0.47 times total assets in FY26. MK Proteins Q2 Results FY27 are best read next to this full-year ratio, and not as a stand-alone signal about how the balance sheet is funded.

Slipping Per-Share Earnings

Per-share earnings slipped over the span from FY22 to FY26, a longer trend that sits beside the stronger quarter. Investors tracking the standalone results can watch whether later filings change that direction.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

MK Proteins Q2 Results FY27 record revenue of Rs 44.46 Cr and net profit of Rs 0.87 Cr in the quarterly results declared on 13 November 2026. Against the same period last year every reported line is higher, and the standalone results basis describes the company on its own. Readers can revisit MK Proteins Q2 Results data on the Univest app, and should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on MK Proteins Q2 Results FY27

What are MK Proteins Q2 Results FY27?

Ans. MK Proteins Q2 Results FY27 are the standalone quarterly results for July to September 2026, showing revenue of Rs 44.46 Cr and net profit of Rs 0.87 Cr, as covered in the opening sections of this article.

What is the results date for MK Proteins Q2 Results FY27?

Ans. The results date is 13 November 2026, when MK Proteins declared its quarterly results. This date anchors the Quick Answer and the Financial Highlights table, which compare the quarter with the same quarter last year.

What revenue was reported in MK Proteins Q2 Results FY27?

Ans. MK Proteins reported standalone revenue of Rs 44.46 Cr for the quarter, compared with Rs 32.43 Cr a year earlier. The Financial Highlights table sets out this revenue comparison beside the other reported lines.

What net profit was reported in MK Proteins Q2 Results FY27?

Ans. Net profit was Rs 0.87 Cr in the quarter against Rs 0.75 Cr in the same quarter last year, which means the PAT line is higher. The Key Takeaways section summarises this movement in one bullet.

How much YoY growth did revenue show in MK Proteins Q2 Results FY27?

Ans. Revenue showed YoY growth of 37.1%, rising from Rs 32.43 Cr to Rs 44.46 Cr in the quarter. Alongside this, the Performance Analysis section compares the growth rates of revenue, Operating Profit and net profit.

Did net profit rise or fall in MK Proteins Q2 Results?

Ans. Net profit rose in MK Proteins Q2 Results, up 16% from Rs 0.75 Cr to Rs 0.87 Cr, so the YoY direction is positive. The Performance Analysis section explains the arithmetic behind this change.

What was the Operating Profit in MK Proteins Q2 Results FY27?

Ans. Operating Profit was Rs 1.47 Cr against Rs 1.05 Cr a year earlier, which means a YoY growth of 40%. The Key Business Factors section lists this gain as the second disclosed factor.

Are MK Proteins Q2 Results standalone results or consolidated results?

Ans. MK Proteins Q2 Results are standalone results, so the Rs 44.46 Cr revenue and Rs 0.87 Cr net profit describe the company on its own. The Quick Answer and the Conclusion both state this basis for readers.

What business factors shaped MK Proteins Q2 Results FY27?

Ans. Three business factors shaped MK Proteins Q2 Results FY27: revenue growth of 37.1% year on year, Operating Profit up 40% to Rs 1.47 Cr, and net profit up 16.0% to Rs 0.87 Cr, all covered in Key Business Factors.

What are the key risks after MK Proteins Q2 Results FY27?

Ans. The disclosed risks after MK Proteins Q2 Results FY27 are return on equity of 9.37% and debt at 0.47 times total assets, for FY26, plus slipping per-share earnings, as set out in Key Risks to Watch.

What is the outlook after MK Proteins Q2 Results?

Ans. The outlook after MK Proteins Q2 Results depends on the quarters still to be declared in FY27, since one quarter does not set the full year. The FY27 Outlook section explains how to track that progress.

Where can I find the complete MK Proteins Q2 Results FY27 data?

Ans. The complete MK Proteins Q2 Results FY27 data sits in the Financial Highlights table above, with revenue, net profit and YoY growth, and further company updates are on the Univest Screener and the Univest app.